In PTEN-deficient tumor models, enhanced LOX production is responsible for the enhanced attraction of macrophages via the β1 integrin-PYK2 pathway, which subsequently promote tumor growth via SPP1 (Chen et al., 2019b). Here, SPP1 is linked to neoplasm.